WASHINGTON, D.C. — U.S. President Donald Trump has officially launched TrumpRx.gov, a new government-backed website designed to help Americans find lower-cost prescription medications and compare drug prices across participating pharmacies and manufacturers.
The initiative, unveiled during a White House event, is part of the administration’s broader effort to reduce healthcare costs and increase transparency in the pharmaceutical market. According to the White House, the platform allows consumers to search for medications, access discounted pricing, and obtain savings coupons that can be used at participating pharmacies across the United States.
Speaking during the launch, Trump described the website as a major step toward lowering out-of-pocket expenses for American families.
“This is about putting patients first and giving Americans access to the best possible prices on their medications,” the president said.
The website highlights discounts negotiated under the administration’s Most Favored Nation (MFN) pricing strategy, which seeks to align U.S. drug prices more closely with those paid in other developed countries. The platform also provides access to generic medications and cash-payment options for consumers who may find lower prices outside their insurance plans.
According to information published on the site, users can search for available medications, compare prices, and access manufacturer-sponsored discounts. Officials say the program is intended to provide greater transparency in a market where drug pricing is often difficult for consumers to understand.
Supporters of the initiative argue that TrumpRx.gov empowers patients by giving them direct access to pricing information and alternative purchasing options. The administration says the platform will continue to expand, with additional medications and participating providers expected to be added in the coming months.
However, critics have questioned whether the website will significantly reduce overall healthcare spending, noting that similar prescription discount services already exist in the private sector. Others have raised concerns about the use of the president’s name in a government-operated website, describing it as an unusual branding decision for a federal initiative.
Despite the debate, the launch of TrumpRx.gov represents one of the most visible healthcare-related projects of Trump’s current term and signals the administration’s intention to focus on prescription drug affordability as a key policy issue.
The website is now available nationwide and allows users to search medications by name and location to identify available discounts in their area
